Notícias e Atividades da Jnana Therapeutics

Fusão, aquisição e financiamento envolvendo Jnana Therapeutics.

• Otsuka Pharmaceutical has announced the acquisition of Jnana Therapeutics  (publicado em 1 de agosto de 2024).

Veja o organograma con seus 19 executivos principais

Biografias mais buscadas da Jnana Therapeutics

• Joanne Kotz, Director, President and Chief Executive Officer
• Annie Chen, Director
• Matthew Hammond, Director

Recentes movimentos de executivos em Jnana Therapeutics

• Ron Renaud, Director, deixou a Companhia  (Notícia publicada em 4 de outubro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Jnana Therapeutics.

Jnana Therapeutics possui 2.339 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Biogen (Estados Unidos).

Popular M&A news in Biotecnologia

• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (publicado em 30 de abril de 2025)..
• Deepull acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 29 de abril de 2025).
• Biolinq acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 23 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Herriot Tabuteau - Chief Executive Officer and Director da Axsome Therapeutics
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Jnana Therapeutics

• News & Insights | Jnana Therapeutics
• Jnana Therapeutics to Present Preclinical Data for its PKU Program at the 2022 National PKU Alliance (NPKUA) Conference • Jnana Therapeutics
• Jnana Therapeutics Announces Appointment of Doug Pagán, MBA, as Chief Financial Officer and Chief Operating Officer • Jnana Therapeutics
• Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to President and Chief Scientific Officer • Jnana Therapeutics
• Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference • Jnana Therapeutics
• Jnana Therapeutics Announces Appointment of John Throup, Ph.D. as Senior Vice President, Head of Development • Jnana Therapeutics
• Jnana Therapeutics to Advance JNT-517 as Development Candidate and Potential First-in-Class Oral Treatment for PKU • Jnana Therapeutics
• Jnana Therapeutics closes $50 million Series B financing to advance lead PKU program and small molecule pipeline based on next gen chemoproteomic platform • Jnana Therapeutics
• Jnana Therapeutics Expands Leadership Team with Two Experienced Biopharmaceutical Executives • Jnana Therapeutics
• Jnana Therapeutics Appoints Dr. Annie Chen to Board of Directors and Dr. Katalin Susztak to Scientific Advisory Board • Jnana Therapeutics
• View more press releases Close

Redes sociais sobre Jnana Therapeutics

• Jnana Therapeutics na Wikipedia, Google News e Yahoo Finance
• Jnana Therapeutics na LinkedIn, Twitter e YouTube